Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2025-12-25 @ 7:10 PM
NCT ID:
NCT02031432
Group ID:
EG000
Title:
Cebranopadol
Description:
Cebranopadol: Cebranopadol 200 µg to 1000 µg per day taken once a day in the morning.
Subjects who completed the treatment in KF6005/07 and were willing to participate in this trial went into a Titration Phase (approximately 2 weeks). During the Titration Phase, the subjects were titrated to their individual optimal daily dose of cebranopadol, defined as a balance between self-reported analgesia and side effects.
Deaths Number Affected:
10
Deaths Number At Risk:
None
Serious Number Affected:
32
Serious Number At Risk:
76
Other Number Affected:
63
Other Number At Risk:
76
Study:
NCT02031432
Results Section:
NCT02031432
Adverse Events Module:
NCT02031432